Marshall Financial Group (Maryland)’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.93M Sell
1,613
-188
-10% -$192K 0.28% 72
2026
Q1
$1.66M Sell
1,801
-46
-2% -$46.6K 0.27% 74
2025
Q4
$1.98M Sell
1,847
-1,210
-40% -$1.16M 0.39% 57
2025
Q3
$2.33M Buy
3,057
+69
+2% +$51.3K 0.45% 48
2025
Q2
$2.31M Sell
2,988
-1,105
-27% -$859K 0.45% 44
2025
Q1
$3.38M Sell
4,093
-79
-2% -$65.7K 0.74% 25
2024
Q4
$3.22M Buy
4,172
+7
+0.2% +$5.8K 0.78% 24
2024
Q3
$3.69M Sell
4,165
-67
-2% -$60.2K 0.88% 23
2024
Q2
$3.83M Sell
4,232
-100
-2% -$80K 1.07% 19
2024
Q1
$3.37M Hold
4,332
0.97% 18
2023
Q4
$2.53M Sell
4,332
-1,043
-19% -$609K 0.81% 27
2023
Q3
$2.89M Sell
5,375
-158
-3% -$81.4K 1.04% 20
2023
Q2
$2.6M Sell
5,533
-29
-0.5% -$12.2K 0.88% 26
2023
Q1
$1.91M Sell
5,562
-331
-6% -$112K 0.69% 39
2022
Q4
$2.16M Sell
5,893
-577
-9% -$205K 0.84% 34
2022
Q3
$2.09M Sell
6,470
-3
-0% -$951 0.88% 21
2022
Q2
$2.1M Sell
6,473
-571
-8% -$171K 0.84% 24
2022
Q1
$2.02M Buy
7,044
+262
+4% +$67.4K 0.83% 19
2021
Q4
$1.87M Buy
6,782
+554
+9% +$140K 0.69% 27
2021
Q3
$1.44M Buy
6,228
+195
+3% +$48.1K 0.74% 21
2021
Q2
$1.39M Sell
6,033
-1,215
-17% -$244K 0.75% 22
2021
Q1
$1.35M Buy
7,248
+120
+2% +$23.5K 0.81% 36
2020
Q4
$1.2M Buy
+7,128
New +$1.06M 0.79% 46

Other funds holding LLY

Marshall Financial Group (Maryland)'s LLY Position: Q2 2026 in Review

Marshall Financial Group (Maryland) reduced its Eli Lilly (LLY) stake by 10% in Q2 2026, selling an estimated $192K and leaving 1,613 shares worth $1.93M. The position accounts for 0.28% of the portfolio, ranked #72.

Marshall Financial Group (Maryland) first reported a position in LLY in Q4 2020 and has held it in 23 quarters since. The position peaked at $3.83M in Q2 2024. 1,844 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Marshall Financial Group (Maryland) held 1,613 shares of Eli Lilly worth $1.93M as of Q2 2026.
  • Marshall Financial Group (Maryland) sold 188 Eli Lilly shares in Q2 2026, an estimated $192K.
  • Eli Lilly made up 0.28% of Marshall Financial Group (Maryland)'s portfolio in Q2 2026, its #72 holding.
  • Marshall Financial Group (Maryland) first reported a position in Eli Lilly in Q4 2020 and has held it in 23 quarters since.
  • Marshall Financial Group (Maryland)'s Eli Lilly position peaked at $3.83M in Q2 2024.
  • 1,844 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Marshall Financial Group (Maryland)'s 13F filing for Q2 2026, filed 20 Jul 2026.